Wednesday, April 22, 2009

Creating and Sustaining Successful Pharma & Biotech Alliance Teams

Alliances in the pharma and biotech industries are on the rise, growing over 80% over the last 10 years. The problem is that as many as 60% to 70% of these alliances underperform or even fail. Yet despite such past performance, most companies expect to continue to form strategic alliances. If alliances remain an inevitable part of corporate strategy, pharma and biotech companies must learn how to create and sustain successful alliances.

Drawing on experience working with such companies as Pfizer, Biogen Idec, Boehringer Ingelheim, and P&G Pharmaceuticals and their alliance teams, Lynda McDermott provides conference attendees with insight into the best practices and relevant tools for launching and developing successful alliance teams.

Creating and Sustaining Successful Pharma & Biotech Alliance Teams is being presented by Lynda McDermott, President, with EquiPro International and airs on Wednesday, May 27, 2009. For more details or to register, please visit our site at www.fxconferences.com